Pricing Log in Create free account
Friday 6 November 2026 Export CLDX’s income statement to Excel — free account

Celldex Therapeutics, Inc.

CLDX Healthcare Biotechnology

Celldex Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 million, down 78.0% from fiscal 2024.

Revenue
−96.8%
EPS
−10.6%
Free cash flow
−35.5%

Quarter to June 2026, against a year earlier

29.90 1.63 +5.77%
Market cap
$2.2B
P/E
0.0×
Fwd P/E
−7.2×
Dividend yield
—
F-score
2/9
Altman Z
14.41
Beneish M
6.76
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Celldex Therapeutics, Inc. (CLDX) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, Celldex Therapeutics, Inc. (CLDX) trades at a P/B ratio of 3.1×. Over the past ten years it has ranged from 0.2× (March 2020) to 13.4× (March 2015); the current reading is higher than 57% of that period. That is above the Biotechnology industry median of 2.0× and above the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 3.4× 57.09%
FY2024 2.2× (52.25%)
FY2023 4.6× (26.86%)
FY2022 6.2× 57.93%
FY2021 3.9× 59.21%
FY2020 2.5× 620.84%
FY2019 0.3× 37.64%
FY2018 0.3× (84.26%)
FY2017 1.6× 15.00%
FY2016 1.4× (73.69%)

Quarterly newest first

Period P/B ratio Change
Jun 2026 4.1× (12.42%)
Mar 2026 4.6× 35.24%
Dec 2025 3.4× 66.01%
Jun 2025 2.1× 20.28%
41 more quarters

Against its own ten years

Low 0.2× High 13.4×
Ten-year median 2.7×
Current reading's percentile 62

P/B ratio against peers

Company P/B ratio
BHVN Biohaven Ltd. compare n/m
CLDX Celldex Therapeutics, Inc. 3.1×
AUPH Aurinia Pharmaceuticals Inc compare 3.3×
IMNM Immunome, Inc. compare 3.9×
VERA Vera Therapeutics, Inc. compare 5.3×
PHVS Pharvaris N.V. compare 6.4×
ADMA ADMA Biologics Inc compare 6.7×
VCEL Vericel Corporation compare 6.8×
PVLA Palvella Therapeutics, Inc. compare 10.4×
Biotechnology industry median 2.0×
Healthcare sector median 2.3×
Market median 1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on CLDX